Economic burden of colorectal cancer in Korea

Ju Young Byun, Seok-Jun Yoon, In Hwan Oh, Young Ae Kim, Hye Young Seo, Yo Han Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

Original languageEnglish
Pages (from-to)84-93
Number of pages10
JournalJournal of Preventive Medicine and Public Health
Volume47
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Korea
Colorectal Neoplasms
Economics
Costs and Cost Analysis
Cost of Illness
International Classification of Diseases
Primary Prevention
Health Insurance
Secondary Prevention
Life Style
Survival Rate
Technology
Incidence
Therapeutics
Population

Keywords

  • Colorectal neoplasms
  • Cost of illness
  • Economic burden
  • Prevalence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Economic burden of colorectal cancer in Korea. / Byun, Ju Young; Yoon, Seok-Jun; Oh, In Hwan; Kim, Young Ae; Seo, Hye Young; Lee, Yo Han.

In: Journal of Preventive Medicine and Public Health, Vol. 47, No. 2, 01.01.2014, p. 84-93.

Research output: Contribution to journalArticle

Byun, Ju Young ; Yoon, Seok-Jun ; Oh, In Hwan ; Kim, Young Ae ; Seo, Hye Young ; Lee, Yo Han. / Economic burden of colorectal cancer in Korea. In: Journal of Preventive Medicine and Public Health. 2014 ; Vol. 47, No. 2. pp. 84-93.
@article{05fb0b9c91c245488f8eecba5948f9cd,
title = "Economic burden of colorectal cancer in Korea",
abstract = "Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85{\%}), respectively and indirect costs were 1 trillion and 160 billion (37.15{\%}), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.",
keywords = "Colorectal neoplasms, Cost of illness, Economic burden, Prevalence",
author = "Byun, {Ju Young} and Seok-Jun Yoon and Oh, {In Hwan} and Kim, {Young Ae} and Seo, {Hye Young} and Lee, {Yo Han}",
year = "2014",
month = "1",
day = "1",
doi = "10.3961/jpmph.2014.47.2.84",
language = "English",
volume = "47",
pages = "84--93",
journal = "Journal of Preventive Medicine and Public Health",
issn = "1975-8375",
publisher = "Korean Society for Preventive Medicine",
number = "2",

}

TY - JOUR

T1 - Economic burden of colorectal cancer in Korea

AU - Byun, Ju Young

AU - Yoon, Seok-Jun

AU - Oh, In Hwan

AU - Kim, Young Ae

AU - Seo, Hye Young

AU - Lee, Yo Han

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

AB - Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

KW - Colorectal neoplasms

KW - Cost of illness

KW - Economic burden

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84899407806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899407806&partnerID=8YFLogxK

U2 - 10.3961/jpmph.2014.47.2.84

DO - 10.3961/jpmph.2014.47.2.84

M3 - Article

C2 - 24744825

AN - SCOPUS:84899407806

VL - 47

SP - 84

EP - 93

JO - Journal of Preventive Medicine and Public Health

JF - Journal of Preventive Medicine and Public Health

SN - 1975-8375

IS - 2

ER -